
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : NIDB-3101
Therapeutic Area : Neurology
Study Phase : Preclinical
Recipient : InSysBio
Deal Size : Undisclosed
Deal Type : Collaboration
InSysBio Announces Its Collaboration with Discoveric Bio Alpha
Details : The collaboration aims to advance the NIDB-3101, which is being evaluated for the treatment of Alzheimer’s disease.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Undisclosed
March 19, 2025
Lead Product(s) : NIDB-3101
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Recipient : InSysBio
Deal Size : Undisclosed
Deal Type : Collaboration
